Related Experiment Video

Updated: May 22, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

Placebo power

Katherine B Knox1, Michael E Kelly

  • 1Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatchewan, Canada. katherine.knox@saskatoonhealthregion.ca

Techniques in Vascular and Interventional Radiology
|May 30, 2012
PubMed

Insights

The placebo response in multiple sclerosis (MS) trials, particularly for endovascular procedures, presents challenges. Understanding placebo effects is crucial for designing future MS studies.

Area of Science:

  • Neuroimmunology
  • Clinical Trial Design
  • Medical Ethics

Background:

  • Variable placebo responses are documented in multiple sclerosis (MS) and other sham surgery trials.
  • Conditioning and expectancy models offer biological explanations for placebo effects.
  • Neuroimmune mechanisms in MS may interact with placebo and treatment responses.

Purpose of the Study:

  • To address the scientific and ethical challenges of measuring placebo response in endovascular MS trials.
  • To highlight the potential for significant placebo responses in MS endovascular procedures.
  • To emphasize the need to consider placebo response factors in future study designs.

Main Methods:

  • Literature review of placebo response factors in MS and sham surgery.
  • Analysis of conditioning and expectancy models for placebo mechanisms.
  • Estimation of placebo response magnitude based on known influencing factors.

Main Results:

  • Placebo responses are variable and influenced by conditioning and expectancy.
  • Neuroimmune involvement in MS suggests complex interactions between placebo and treatment effects.
  • Significant placebo responses are anticipated for endovascular procedures in MS.

Conclusions:

  • Measuring placebo response in endovascular MS trials is scientifically and ethically complex.
  • Factors associated with larger placebo responses should be carefully considered.
  • Future studies investigating endovascular procedures for MS must account for potential placebo effects.

More Related Videos

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Related Concept Videos

The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Statistical Significance01:37

Statistical Significance

Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...